Solid Biosciences is merging with Sarepta-backed AavantiBio in a $215m deal while Amazon has formed a minority founder-focused $150m fund.

M&A

Nasdaq-listed Duchenne muscular dystrophy therapy developer Solid Biosciences is merging with AavantiBio, a US-based gene therapeutics provider backed by genetic medicine group Sarepta Therapeutics, through a $215m cash and investment deal.

Business management automation tool provider ZenBusiness has acquired Ureeka, a US-based minority founder-focused mentoring platform backed by enterprise software firm Salesforce, for an undisclosed amount.

Cosmetics firm Shiseido has agreed to acquire Gallinée, a…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Edison Fu

Edison Fu is a reporter and Asia liaison at Global Corporate Venturing.
Email LinkedIn